The ICH guidance Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients is intended to provide guidance regarding good manufacturing practice (GMP) for the manufacturing of active pharmaceutical ingredients (APIs) under an appropriate system for managing quality. It is also intended to help ensure that APIs meet the quality and purity characteristics that they purport, or are represented, to possess.
News & Trends
Procurar
Recentes
- Monitoring the European clinical trials environment
- THE MEDICRIME CONVENTION IN 10 QUESTIONS AND ANSWERS
- Qualificação de FORNECEDORES 2026 : “Formação muito completa “
- GMP/GDP Update for Cannabis.
- BOAS PRÁTICAS de DISTRIBUIÇÃO de MEDICAMENTOS : “Formação muito interessante e enriquecedora”
- Commission welcomes political agreement on Critical Medicines Act
- Study supporting the monitoring of the availability of medical devices on the EU market
- GDP AUDITS 2026 : “Tema muito bem explicado , com a resolução de casos práticos”

